Jinichi Mori Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

2/2023	Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10).
12/2020	Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT.
1/2020	Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
1/2020	Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
12/2019	Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.
9/2019	Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.
1/2019	Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
1/2019	Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.
1/2018	Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15).
1/2018	Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinichi Mori Research Topics

Disease

12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2023 - 01/2011
10	Neoplasms (Cancer) 01/2023 - 11/2015
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 11/2016
3	Carcinogenesis 01/2021 - 11/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2020 - 08/2013
2	Sepsis (Septicemia) 05/2020 - 01/2012
2	Breast Neoplasms (Breast Cancer) 06/2017 - 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Nephrosclerosis 07/2020
1	Chronic Renal Insufficiency 07/2020
1	Wounds and Injuries (Trauma) 05/2020
1	Uremia 05/2020
1	Bites and Stings (Sting) 05/2020
1	Acute Promyelocytic Leukemia 01/2020
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2020
1	Leukemia 01/2020
1	Multiple Myeloma 01/2018
1	IGA Glomerulonephritis (IGA Nephropathy) 12/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2017
1	Inflammation (Inflammations) 01/2017
1	Gastritis 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Adenocarcinoma 01/2017
1	Infections 01/2017
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2015
1	Liver Neoplasms (Liver Cancer) 11/2015
1	Thrombocytopenia (Thrombopenia) 03/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2012
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2012
1	Acute Kidney Injury (Acute Renal Failure) 01/2012

Drug/Important Bio-Agent (IBA)

2	blinatumomabIBA 01/2023 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2021
2	AndrogensIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022
1	ChromatinIBA 01/2022
1	Testosterone CongenersIBA 01/2022
1	LigandsIBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	nilotinib FDA Link 07/2020
1	Dasatinib (BMS 354825)FDA Link 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	CD52 AntigenIBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	AntigensIBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	carfilzomibIBA 01/2018
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2017
1	Zoledronic Acid (Zometa)FDA Link 11/2017
1	Rituximab (Mabthera)FDA Link 10/2017
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2017
1	epsinIBA 01/2017
1	Inotuzumab OzogamicinIBA 11/2016
1	Inositol (Myoinositol)IBA 06/2016
1	Cystatin CIBA 03/2016
1	IronIBA 11/2015
1	sulofenur (ISCU)IBA 11/2015
1	AA amyloidosisIBA 08/2013
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2012

Therapy/Procedure

7	Cell Transplantation 01/2020 - 01/2016
5	Hematopoietic Stem Cell Transplantation 02/2023 - 01/2012
5	Transplantation 12/2020 - 01/2019
4	Stem Cell Transplantation 01/2023 - 10/2017
3	Therapeutics 01/2023 - 12/2017
2	Renal Dialysis (Hemodialysis) 07/2020 - 05/2020
1	Aftercare (After-Treatment) 01/2022
1	Radiotherapy 01/2021
1	Punctures 05/2020
1	Palliative Care (Palliative Therapy) 12/2018
1	Nuclear Power Plants 12/2015
1	Platelet Transfusion (Blood Platelet Transfusions) 03/2013
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2012